Long‐term inhibition of VEGF‐A may lead to undesired age‐promoting effects64, 65 and, therefore, anti‐VEGF‐A therapy for the management of psoriasis may best be administered as repetitive pulse therapy. This evidence concerns the gene VEGFA and psoriasis.